White Paper
Leveraging Real-World Data for the Targeted Treatment of Cancer
A focus on Bladder Cancer - a highly heterogeneous disease
Understanding the intricacies of treating cancer and the challenges faced when integrating clinical trial data into the clinicians’ decision-making is fundamental to appreciating and leveraging the opportunities related to Real-World Data (RWD) and its use. Bladder cancer, with its high degree of heterogeneity, is one example of where RWD can be of particular benefit.
Discover how BC Platforms leverages its expertise in health data management and secure collaborations to revolutionize cancer treatment strategies.
Download the white paper to gain insights on:
-
How RWD complements clinical trials by reflecting real-world patient populations
-
How RWD can help clinicians make better-informed treatment decisions
-
Future perspectives on integrating predictive AI models with RWD
HEAR FROM THE EXPERT
"With the rise of Real-World Data, we are on the brink of transforming treatment approaches, offering hope where there was once uncertainty. This initiative marks a critical step towards better patient outcomes in this complex disease."
- Dr. Manuel Castanheira de Oliveira
UROLOGIST, CENTRO HOSPITALAR DE SANTO ANTÓNIO, PORTUGAL